University of Florida Identified Immune Cells in Pancreas
Researchers found self-renewing stem-like cells that sustain the autoimmune attacks in type 1 diabetes patients.
Updated on Sept. 22, 2026 in Diabetes
Live Poll
Do you believe recent medical research breakthroughs are making chronic disease management more effective?
University of Florida scientists have identified self-renewing stem-like T cells residing in lymph nodes near the pancreas. These immune cells are responsible for continuously replenishing the population of T cells that destroy insulin-producing beta cells in type 1 diabetes.
Why it matters
This discovery helps explain why autoimmune attacks in type 1 diabetes can persist for many years. By identifying the source of these persistent immune cells, researchers may eventually develop targeted therapies to stop the disease at its root.
The study analyzed immune cells using single-cell gene sequencing from organ donor pancreatic tissue and nearby lymph nodes. Researchers identified distinct stem-like T cells that perpetuate autoimmune activity.
The players
University of Florida
This public research university in Gainesville is a leading institution for diabetes and immunology research.
Journal of Clinical Investigation
This is a peer-reviewed medical journal that publishes original research on the investigation of human disease.
The details
Researchers utilized single-cell gene sequencing to track the active genes within immune cells from pancreatic tissue and surrounding lymph nodes. The study revealed that these stem-like cells consistently renew themselves, providing a steady supply of cells that attack the body's insulin-producing capabilities.
Timeline
September 15, 2026: The study was published in the Journal of Clinical Investigation.
July 2026: The University of Florida published a separate study on inflammation.
The Big Picture
This discovery shifts the paradigm of type 1 diabetes research by identifying the specific cellular source of persistent immune attacks. It builds upon the ongoing type 1 diabetes autoimmune research at the University of Florida by providing a new target for potential future antibody therapies.
While this discovery provides a new target for future research, it does not change current clinical care for type 1 diabetes patients. Any potential medical treatment derived from these findings remains years away and would require rigorous clinical trial testing.
The takeaway
Understanding how immune cells renew themselves is a critical step toward developing long-term strategies to manage autoimmune diseases. Residents in Gainesville and beyond should note that this is a foundational scientific discovery rather than an immediate change in medical treatment.
Further reading
For more on the current medical approaches to managing this condition, see Diabetes.
Source note: This article includes information reported by Medical Daily.
Live Poll
Do you believe recent medical research breakthroughs are making chronic disease management more effective?
